<DOC>
	<DOC>NCT00763217</DOC>
	<brief_summary>In a previous suty, we have demonstrated that prior transient ischemic attack, treatment lipid-lowering drug or physical activity are associated to a better outcome of stroke. The aim of the study is to understand the mechanisms of this preventive neuroprotection by establishing link between biomarkers and preventive and neuroprotective measures.To answer to the question, we conduct a cohort study of stroke patients.</brief_summary>
	<brief_title>Clinical Biological and Pharmacological Factors Influencing Stroke Outcome</brief_title>
	<detailed_description>In the cohort, the severity of stroke (NIHSS) will be correlated with : - clinical factors, - pharmacological factors, - biological factors (inflammatory markers, hemostasis...)</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>ischemic or hemorrhage stroke hemispheric stroke stroke dating from less 48h non hemispheric stroke malformative intracranial hemorrhage traumatic intracranial hemorrhage subarachnoidal hemorrhage</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>inflammation</keyword>
	<keyword>coagulation</keyword>
	<keyword>neuroprotection</keyword>
	<keyword>drugs</keyword>
	<keyword>clinical neurology</keyword>
	<keyword>pharmacology</keyword>
	<keyword>biological factors</keyword>
</DOC>